Slider Slider
The Origin of Brand Redsenol
The brand name "Redsenol" derives its inspiration from the concept that "Red Ginseng Is Noble", embodying an ambitious goal to become the leading red ginseng brand. While Redsenol's active ingredients are originated from red ginseng, it surpasses the boundaries of traditional red ginseng products by offering an extract that contains highly bioactive and absorbable rare ginsenosides.

From 2005 to 2014, the R&D team strived to conquer technical barriers in bulk production of the rare ginsenosides Rg3, Rh2, Rh1, aPPD, aPPT, etc., and the more hard-to-obtain rare ginsenosides Rk1, Rk2, Rh3, Rg5, etc. on a large scale. The R&D team conducted plenty of research on the mechanisms of action of rare ginsenosides and confirmed their functions in enhancing human health.

Redsenol, headquartered in Vancouver, Canada, is a brand under by Canada Royal Enoch Phytomedicine Ltd. Redsenol is committed to using existing metabolic derivatives and transformation derivatives as precursors to synthesize new drug molecules with higher activity through unique design technology, and continues to carry out basic research and technological innovation to maintain technical advantages in the industrial preparation of intermediates. At the same time, Redsenol continues to develop new preparation technologies to improve bioavailability, reduce production costs, and benefit more users.

From Christian to Chief Scientist Specialized in Herbal Extraction
Named after the biblical figure who walked with the God for three hundred years before God took him, Canada Royal Enoch Phytomedicine Ltd. originated in faith and vision. Dr. Peihua Yu earned his Ph.D. from Germany and worked as a postdoctoral research fellow in Canada before becoming chief scientist at Enoch.
Years after Dr. Yu settled in Canada, his sister's suffering from stomach discomfort in 2011 brought him onto the quest for a safe and active agent. Could there be another option? Dr. Yu's endless search led him to natural herbs as the best field of hope.
Devoted to Herbal Medicine Research,
We do Four Things
Heat-processing in the preparation of traditional Chinese medicine is similar to herbal processing in western medicine, and many such processed intermediates have to be metabolized in the body to become the final active ingredients.
Taking rare ginsenosides as an example, they are not readily obtainable from Araliaceae ginseng plants (Asian ginseng, American ginseng,panax notoginseng,etc.), and the raw plants must first be heat-processed and then be metabolized and/or biotransformed in vitro (outside the body) to form rare ginsenosides. At this stage, the final products are totally different from what is known as traditional Chinese medicine, or herbal medicine as known by westerners.
Firstly, plenty of biomedical research reports that ginsenosides in their natural-occurring forms (prototype ginsenosides), cannot be directly absorbed into the human body. They must first undergo proper gastrointestinal metabolism and be converted into rare ginsenosides before effective absorption could take place. This proposes considerable difficulties for individuals with poor digestive functions.
Secondly, we devote to quality-based Araliaceae ginseng selection and in improving our drug preparation technology, so more metabolized and/or biotransformed active ingredients could be obtained. We choose to build our manufacturing workshop in Canada's Vancouver because North America provides a suitable environment for the growth of ginseng.
Thirdly, rare ginsenosides are neither water-soluble nor lipid-soluble, and it is not easy for rare ginsenosides to reach the site of action inside the human body. Our R&D team devotes to finding a solution to transport rare ginsenosides inside the body.
Lastly, we focus on the specific healthy function and safety experiments, starting from in vitro cell culture experiments, to in vivo animal experiments, and eventually to human clinical trials, we invite internationally-recognized third party authorities for result verification.
The Birth of the Redsenol Multiple
Rare Ginsenoside
The Birth of the Redsenol Multiple
Redsenol Rare Ginsenosides capsule features 16 rare ginsenosides, i.e. Rk2, Rg3 (S, R), Rh2(S, R), Rg5, Rk1, Rk3, Rh1(S, R), Rh3, Rh4, aPPT(S, R), aPPD(S, R). These active ingredients act together to exert synergistic effects and multiple rare ginsenosides are more effective than single ginsenoside.
Redsenol-DAG sublingual pill is made of 8 highly active rare ginsenosides that are meticulously selected, i.e. Rk1, Rk2, Rh3, Rg5, aPPT(S, R), aPPD(S, R). The high concentration of the 8 highly active compounds makes it more targeted.
Although Redsenol Rare Ginsenosides capsules and Redsenol-DAG sublingual pills are licensed as a natural health product by Health Canada, it has more medicinal properties in that it has a clear composition, clear efficacy, and reliable quality.